A study of efficacy and predictive factors of oral Spironolactone treatment in Chronic Central Serous Retinopathy.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- TO study predictive factors for positive response to oral spironolactone treatment among cases of chronic CSR.
研究概览
简要总结
It is an observational study being conducted at SMS Medical College and Hospital, at Department of Ophthalmology to evaluate the predictive factors for resolution of edema in the patients of Chronic Central Serous Retinopathy after giving the treatment of Tab Spironolactone for 3 months. All patients diagnosed with chronic CSR will be enrolled and started on Tab Spironolactone 25mg BD for a period of 3 months and will be evaluated for the resolution of edema on OCTA at one week, one month and three months.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 50.00 Year(s)(—)
- 性别
- All
入选标准
- •Patient giving informed written consent.
- •Age group 18 to 50 yrs.
- •Chronic Central Serous Retinopathy.
- •Resolution of edema after treatment of Tab Spironolactone.
排除标准
- •Patients with any other macular pathology.
- •Patients with previous photocoagulation laser within one year.
- •Patients with Injection Anti Vascular Growth Factors within one year.
- •Patients with any contraindication to oral Spironolactone such as kidney or liver disease.
- •Patients already taking Tab Spironolactone for some other cause.
结局指标
主要结局
TO study predictive factors for positive response to oral spironolactone treatment among cases of chronic CSR.
时间窗: 1 week, 1 month, 3 months
次要结局
未报告次要终点
研究者
NITISHA BAIRWA
Sawai Man Singh Medical College, Jaipur.
